Skip to content

MedCaT: what changed

BE 0889.559.581NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€5,880
2024 · €3,953+€1,927
Equity
€78,250
2024 · €72,370+€5,880
Cash
€33,116
2024 · €68,469-€35,354
Balance sheet total
€88,066
2024 · €77,420+€10,646

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€46,100

    up €46,100 (+530%), from €8,692 to €54,792

    of which Other amounts receivable: +€43,230

  • Cash -€35,354

    down €35,354 (-51.6%), from €68,469 to €33,116

    mainly Receivables within one year (-€46,100) and Other debts (-€4,320)

Equity and liabilities
  • Trade debts +€8,068

    up €8,068 (+1,106%), from €729 to €8,798

  • Reserves +€5,880

    up €5,880 (+10.9%), from €53,770 to €59,650

  • Other debts -€4,320

    down €4,320 (-100%), from €4,320 to €0

  • Tax, wage and social debts +€1,018

    first reported in 2025, at €1,018

Income statement
  • Gross operating margin +€1,477

    up €1,477 (+23.7%), from €6,238 to €7,715

  • Financial income +€898

    up €898 (+3,979%), from €23 to €920

  • Taxes +€700

    up €700 (+53.1%), from €1,318 to €2,018

  • Financial charges -€128

    down €128 (-27.7%), from €462 to €334

  • Other operating charges -€125

    down €125 (-23.6%), from €528 to €403

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €3,953
Gross operating margin +€1,477
Other operating charges +€125
Financial income +€898
Financial charges +€128
Taxes -€700
Result 2025 €5,880
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€35,354
Investment €0
Financing €0
Cash 2024 €68,469
Net result for the year +€5,880
Receivables within one year -€46,100
Deferred charges and accrued income +€100
Trade debts +€8,068
Tax, wage and social debts +€1,018
Other debts -€4,320
Cash 2025 €33,116
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €77,420 €88,066 +€10,646 +13.8%
Current assets 29/58 €77,420 €88,066 +€10,646 +13.8%
Stocks and contracts in progress 3 €0 - =
Stocks 30/36 €0 - =
Amounts receivable within one year 40/41 €8,692 €54,792 +€46,100 +530%
Trade receivables 40 €7,329 €10,199 +€2,870 +39.2%
Other amounts receivable 41 €1,364 €44,593 +€43,230 +3,170%
Cash at bank and in hand 54/58 €68,469 €33,116 -€35,354 -51.6%
Deferred charges and accrued income 490/1 €258 €158 -€100 -38.8%
Total equity and liabilities 10/49 €77,420 €88,066 +€10,646 +13.8%
Equity 10/15 €72,370 €78,250 +€5,880 +8.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €53,770 €59,650 +€5,880 +10.9%
Distributable reserves 133 €53,770 €59,650 +€5,880 +10.9%
Amounts payable 17/49 €5,050 €9,816 +€4,766 +94.4%
Amounts payable within one year 42/48 €5,050 €9,816 +€4,766 +94.4%
Trade debts 44 €729 €8,798 +€8,068 +1,106%
Suppliers 440/4 €729 €8,798 +€8,068 +1,106%
Taxes, remuneration and social security 45 - €1,018 +€1,018
Taxes 450/3 - €1,018 +€1,018
Other amounts payable 47/48 €4,320 €0 -€4,320 -100%
Accrued charges and deferred income 492/3 €0 - =
Other operating charges 640/8 €528 €403 -€125 -23.6%
Gross operating margin 9900 €6,238 €7,715 +€1,477 +23.7%
Operating profit (loss) 9901 €5,711 €7,312 +€1,601 +28.0%
Financial income 75/76B €23 €920 +€898 +3,979%
Recurring financial income 75 €23 €920 +€898 +3,979%
Financial charges 65/66B €462 €334 -€128 -27.7%
Recurring financial charges 65 €462 €334 -€128 -27.7%
Profit (loss) for the period before taxes 9903 €5,271 €7,898 +€2,627 +49.8%
Income taxes 67/77 €1,318 €2,018 +€700 +53.1%
Profit (loss) for the period 9904 €3,953 €5,880 +€1,927 +48.7%
Profit (loss) for the period to be appropriated 9905 €3,953 €5,880 +€1,927 +48.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€54,347 to €60,435

Midpoint €56,884 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €78,250
Capitalised earnings €30,443 to €42,620
Indication €54,347 to €60,435

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€78,250
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€78,250

Capitalised earnings

net result for the year (9904)
2025
€5,880
2024
€3,953
2023
€2,953
2022
€6,960
2021
€7,091
Average result
€4,262
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€30,443 / €35,517 / €42,620

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.